The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women
Aim To investigate association of factor V Leiden, prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women. Methods A total of 60 women with two or more consecutive miscarriages before 20 weeks of gestation with the same partners and without history of known causes or recurrent pregnancy loss were included. A control group included 80 healthy women who had one or more successful pregnancies without history of any complication which could be associated with miscarriages. Genotyping of factor V Leiden, prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms were performed by polymerase chain reaction/restriction fragments length polymorphism method (PCR/RFLP). Results Both factor V Leiden and MTHFR C677T polymorphisms were significantly associated with recurrent pregnancy loss (RPL) in Bosnian women while prothrombin G20210A and PAI-1 4G/5G polymorphisms did not show strongly significant association. Conclusion The presence of thrombophilic polymorphisms may predispose women to recurrent pregnancy loss. Future investigation should be addressed in order to find when carriers of those mutations, polymorphisms should be treated with anticoagulant therapy.
Kutteh W, Triplett D. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med. 2006;54–6.
2.
Bozikova A, Gabrikova D, Pitonak J, Bernasovska J, Macekova S, Beluhova-Lohajova R. Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (Gypsy) populations. Genet Test Mol Biomarkers. 2015;98–102.
3.
Parand A, Zolghadri J, Nezam M, Afrasaibi A, Haghpanah S, Karimi M. Inherited thrombophilia and recurrent pregnancy loss. Iran Red Crescent Med J. 2013;13708.
4.
Erol R, Schorge J. Obstetrics and Gynecology at a glance. 4 th ed. 2013;
5.
Coulam C, Wallis D, Weinstein J, Dasgupta D, Jejendram R. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol. 2008;426–31.
6.
Dawood F, Mountford R, Ferquharson R, Quenby S. Genetic polymorphisms on the factor V gene in women with recurrent miscarriage an acquired APCR. Hum Reprod. 2007;2546–53.
7.
Mierla D, Szmal C, Neagos D, Cretu R, Stoian V, Jardan D. Association of prothrombin (A20210G) and factor V Leiden (A506G) with recurrent pregnancy loss. J Clin Med. 2012;222–6.
8.
Krishnaswamy S. The transition of prothrombin to thrombin. J Thromb Haemost. 2013;265–76.
9.
Kujovich J. Thrombophilia and pregnancy complications. Am J Obstet Gynecol. 2004;412–24.
10.
Karmali M, Hantoushzadeh S, Borna S, Neamatzadeh H, Mazaheri M, Noori-Shadkam M, et al. Association between thrombophilic genes polymorphisms and recurrent pregnancy loss susceptibility in the Iranian population: a systematic review and meta-analysis. Iran Biomed J. 2018;78–89.
11.
Rey E, Kahn S, David M, Shrier I. Thrombophilic disorders and foetal loss: a meta-analysis. Lancet. 2003;901–8.
12.
Vossen C, Preston F, Conard J, Fontcuberta J, Makris M, Van Der Meer F, et al. Rosendaal FR. Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost. 2004;592–6.
13.
Boas W, Goncalves R, Costa O, Goncalves M. Metabolism and gene polymorphisms of the folate pathway in Brazilian women with history of recurrent abortion. Rev Bras Ginecol Obstet. 2015;71–6.
14.
Wu X, Zhao L, He D, Tang W, Luo Y. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: a meta-analysis. Genet Test Mol Biomarkers. 2012;806–11.
15.
Mtiraoui N, Zammiti W, Ghanzouani L, Braham N, Saidi S, Finan R, et al. Methylenetetrahydrofolatereductase C677T and A1298C polymorphisms and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction. 2006;395–401.
16.
Kurzawinska G, Barlik M, Drews K, Rozicka A, Seramek-Mrozickicwicz A, Ozarowski M, et al. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population. Ginekol Pol. 2016;271–6.
17.
Glueck C, Kupfermic M, Fontaine R, Wang P, Weksler B, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol. 2001;44–8.
18.
Poort S, Rosendaal F, Reitsma P, Bertina R. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;3698–703.
19.
Bertina R, Koelman B, Koster T, Rosendaal F, Dirven R, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1996;64–7.
20.
Froost P, Blom H, Milos R, Goyette P, Sheppard C, Matthews R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolatereductase. Nat Genet. 1995;111–3.
21.
Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, et al. An alternative method for PAI-1 promoter polymorphism. Thromb Haemost. 1997;(4):605–6.
22.
Hugh M, M. The odds ratio: Calculation, usage and interpretation. Biochem Med. 2009;120–6.
23.
El Hachem H, Crepaux V, Panloup M, Descamps P, Legendre P, G, et al. Precurrent pregnancy loss. Int J Womens Health. 2017;331–45.
24.
Nahas R, Saliba W, Elias A, Elias M. The prevalence of thrombophilia in women with recurrent fetal loss and outcome of anticoagulation therapy for the prevention of miscarriages. Clin Appl Thromb Hemost. 2018;122–8.
25.
D’uva M, Micco D, Strina P, Placido I, G. Recurrent pregnancy loss and thrombophilia. Journal of Clinical Medical Research. 2010;18–22.
26.
Mahmutbegovic E, Marjanovic D, Medjedovic E, Mehmetbegovic N, Dogan S, Valjevac A, et al. Prevalence of F5 1691 G>A, F2 20210 G>A and MTHFR 677 C>T polymorphisms in Bosnian women with pregnancy loss. Bos J Basic Med Sci. 2017;309–14.
27.
Finan R, Tamim H, Ameen G, Sharida H, Rashid M, Almawi W. Prevalence of factor V G1691A (Factor V Leiden) and prothrombin gene mutations in a recurrent miscarriage population. Am J Hematol. 2002;300–5.
28.
Alifirevic Z, Mousa H. Thrombophilia and adverse pregnancy outcome. Croat Med J. 2001;135–45.
29.
Habibovic Z, Zeybek B, Sanhal C, Eroglu Z, Karaca E, Ulukus M. Effects of inherited thrombophilia in women with recurrent pregnancy loss. Clin Exp Obstet Gynecol. 2011;347–50.
30.
Rai V. Methylenetetrahydrofolate reductase C677T polymorphism and recurrent pregnancy loss risk in Asian population: a meta-analysis. Indian J Clin Biochem. 2016;402–13.
31.
Torabi R, Zarei S, Zeraati H, Zarnani A, Akhondi M, Hadavi R, et al. Combination of thrombophilic gene polymorphisms as a casuse of increased the risk of recurrent pregnancy loss. J Reprod Infertil. 2012;89–94.
32.
Hefler L, Jireck S, Heim K, Grimm C, Antensteiner G, Zeiliner R, et al. Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine foetal death: a multicentre study. Journal of the Society Gynecologic Investigation. 2004;42–4.
33.
Lykke J, Bare L, Olsen J, Lagier R, Arellano A, Tong C, et al. Langhoff-Roos J. Thrombophilias and adverse pregnancy outcomes: results from Danish National Birth Cohort. Thromb Haemost. 2012;1320–5.
34.
Li X, Liu Y, Zhang R, Tan J, Chen L, Liu Y. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss. Med Sci Monit. 2015;1051–6.
35.
Su M, Lin S, Chen Y, Kuo P. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost. 2013;8–15.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
